Logo NANOPILOT PROJECT

NanoPilot in a private-public workshop: “Foro de Colaboración Público-Privada en Sanidad Animal y Nanotecnología”

Partner USC presented NanoPilot Project in a private-public workshop: “Foro de Colaboración Público-Privada en Sanidad Animal y Nanotecnología” that was held in Madrid on the 15th of September 2015. This workshop was organized by NanoMedicine Spanish Platform (Plataforma Española de NanoMedicina (Nanomed)) together with Spanish Technological Platform for Animal Health (Plataforma Tecnológica Española de Sanidad Animal (Vet+i)). The objective of the workshop was to make public nanomedicine possibilities and potential applications in the field of animal health.

The project was presented in the context of USC research activities as a necessary tool to move forward the pre-clinical research into the clinic. For more information about the content of the event click here .

10 June, 2016 · Overview

BIND Therapeutics Initiates Voluntary Chapter 11 Bankruptcy Protection Proceeding

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- BIND Therapeutics, Inc. (NASDAQ:BIND), a biotechnology company developing targeted and programmable therapeutics called ACCURINS®, today announced that it has elected to file a voluntary petition under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware.
For more information:
Company's web site at www.bindtherapeutics.com, and BANKRUPTCY OF NANOMEDICINE FIRM WORRIES DRUG DEVELOPERS (NATURE VOL 533, 19 MAY 2016 by Heidi Ledford) Read more